August 19, 2014

Pharmacy Advantage on Tuesday launched its mobile device application, Pharm Adv, powered by mscripts.

 

August 18, 2014

The Food and Drug Administration will be hosting an all-day hearing on Sept. 17 seeking public comment on five draft guidance documents related to the implementation of the Generic Drug User Fee Amendments of 2012, as well as input on future policy priorities. 

August 15, 2014

The Food and Drug Administration announced approval of a new use for Avastin (bevacizumab), to treat patients with persistent, recurrent or late-stage cervical cancer.

August 14, 2014

Amneal Pharmaceuticals announced four new additions to its portfolio of generic drugs, which represent multiple therapeutic categories and account for $900 million annually in U.S. sales, the company said, citing data from IMS Health.

August 14, 2014

The Food and Drug Administration has announced approval for Belsomra (suvorexant) tablets, which are used to treat insomnia.

August 14, 2014

Beginning in August, Wegmans Food Markets is now offering an enhanced Specialty Pharmacy Service for medications used to treat conditions in the fields of rheumatology, gastroenterology, neurology and dermatology.

August 13, 2014

The European Union is leading an international pilot project through which, upon request from a generic pharmaceutical company, it will share the assessment reports generated as part of the decentralized procedure in real time with collaborating regulatory agencies outside the EU.

August 12, 2014

Kirby Lester, a pharmacy automation provider, announced that 97% of the company's KL60 and KL100 pharmacy robot users reported that the device improved their pharmacy's operations.

August 11, 2014

CVS/pharmacy celebrated on Monday its entrance into the Seattle market with the grand opening of a new location in the city of Renton, marking the first CVS/pharmacy in the state of Washington.

August 11, 2014

The Food and Drug Administration last week released a draft guidance to assist sponsors and other interested parties in providing information that will help the agency determine the exclusivity period for biologics approved under Section 351(a) of the Public Health Service Act, Bloomberg BNA reported.

August 8, 2014

The Food and Drug Administration earlier this week announced approval for Orbactiv (oritavancin), an antibacterial drug used to treat patients with acute bacterial skin and skin structure infections.

August 8, 2014

Walgreens pulled the trigger on step two of its proposed Alliance Boots merger a full six months early.

 

August 6, 2014

Community pharmacists can dramatically help their patients stick to their prescription regimens, according to a new study led by researchers at the University of Pittsburgh School of Pharmacy.

August 6, 2014

Walgreens said it has exercised its option to complete the second step of its strategic transaction with Alliance Boots ahead of the original option period, which was between February and August 2015.

 

August 6, 2014

Walgreens Boots Alliance will be emphasizing improved front-end margin contributions across its U.S. Walgreens store base once the merger is complete, mirroring the peformance of its U.K. store base Boots, in an effort to counter margin pressures from the pharmacy side of the business. 

August 5, 2014

One-in-four Americans admits that they have misused prescription drugs, according to a new national survey by FindLaw.com.

 

August 5, 2014

Walgreens on Tuesday reported July sales of $6.4 billion, an increase of 6.1% compared to the same month in fiscal 2013.

 

August 4, 2014

The Council for Responsible Nutrition on Friday submitted comments to the Food and Drug Adminisration regarding the agency's proposed rule changes of nutrition and supplement facts labels. 

August 4, 2014

AmerisourceBergen leaders on Friday focused on giving independent pharmacists the tools they need to learn, optimize and grow during the general session of ThoughtSpot 2014, AmerisourceBergen and Good Neighbor Pharmacy’s annual tradeshow.

August 1, 2014

QS/1 is implementing additional security measures to better validate electronic prescriptions for controlled substances, the company announced.

July 31, 2014

The Food and Drug Administration on Friday will publish the fiscal year 2015 generic drug user fee rates as required under the Food Drug and Cosmetic Act as amended by the Generic Drug User Fee Amendments of 2012.

July 31, 2014

Teva Pharmaceuticals on Thursday announced results for second-quarter 2014, which included revenues of $5 billion, an increase of 2% compared with the same period last year.

July 30, 2014

The American Pharmacists Association has announced the election of Jean-Venable “Kelly” Goode of Richmond, Va., as 2015-16 APhA president-elect.

July 30, 2014

Perrigo on Wednesday announced that it has filed an abbreviated new drug application with the Food and Drug Administration for desoximetasone topical spray 0.25%. The company also has notified Taro Pharmaceuticals U.S.A., the owner of the reference listed drug, of the filing.